Biotricity Stock Technical Analysis

BTCY Stock  USD 0.24  0.05  17.24%   
As of the 12th of February 2026, Biotricity shows the Risk Adjusted Performance of (0.12), standard deviation of 6.74, and Mean Deviation of 5.04. Biotricity technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Biotricity Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Biotricity, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BiotricityBiotricity's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Biotricity Analyst Consensus

Target PriceConsensus# of Analysts
4.0Hold1Odds
Biotricity current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Biotricity analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Biotricity stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Biotricity, talking to its executives and customers, or listening to Biotricity conference calls.
Biotricity Analyst Advice Details
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biotricity. Projected growth potential of Biotricity fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Biotricity assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(0.09)
Revenue Per Share
0.589
Quarterly Revenue Growth
0.21
Return On Assets
(0.11)
Return On Equity
(41.01)
Understanding Biotricity requires distinguishing between market price and book value, where the latter reflects Biotricity's accounting equity. The concept of intrinsic value - what Biotricity's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Biotricity's price substantially above or below its fundamental value.
It's important to distinguish between Biotricity's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biotricity should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Biotricity's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

Biotricity 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biotricity's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biotricity.
0.00
11/14/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/12/2026
0.00
If you would invest  0.00  in Biotricity on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Biotricity or generate 0.0% return on investment in Biotricity over 90 days. Biotricity is related to or competes with Aurora Spine, Guided Therapeutics, and Cell Source. Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United Sta... More

Biotricity Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biotricity's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biotricity upside and downside potential and time the market with a certain degree of confidence.

Biotricity Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Biotricity's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biotricity's standard deviation. In reality, there are many statistical measures that can use Biotricity historical prices to predict the future Biotricity's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biotricity's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.020.317.28
Details
Intrinsic
Valuation
LowRealHigh
0.061.188.15
Details
1 Analysts
Consensus
LowTargetHigh
3.644.004.44
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.08-0.08-0.08
Details

Biotricity February 12, 2026 Technical Indicators

Biotricity Backtested Returns

Biotricity secures Sharpe Ratio (or Efficiency) of -0.17, which signifies that the company had a -0.17 % return per unit of risk over the last 3 months. Biotricity exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biotricity's Standard Deviation of 6.74, risk adjusted performance of (0.12), and Mean Deviation of 5.04 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.0186, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Biotricity are expected to decrease at a much lower rate. During the bear market, Biotricity is likely to outperform the market. At this point, Biotricity has a negative expected return of -1.19%. Please make sure to confirm Biotricity's jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if Biotricity performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.26  

Poor predictability

Biotricity has poor predictability. Overlapping area represents the amount of predictability between Biotricity time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biotricity price movement. The serial correlation of 0.26 indicates that nearly 26.0% of current Biotricity price fluctuation can be explain by its past prices.
Correlation Coefficient0.26
Spearman Rank Test0.11
Residual Average0.0
Price Variance0.0
Biotricity technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Biotricity technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Biotricity trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Biotricity Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Biotricity across different markets.

About Biotricity Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Biotricity on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Biotricity based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Biotricity price pattern first instead of the macroeconomic environment surrounding Biotricity. By analyzing Biotricity's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Biotricity's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Biotricity specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2024 2025 2026 (projected)
Dividend Yield0.0014010.0040970.0036870.003503
Price To Sales Ratio1.070.530.610.58

Biotricity February 12, 2026 Technical Indicators

Most technical analysis of Biotricity help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Biotricity from various momentum indicators to cycle indicators. When you analyze Biotricity charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Biotricity February 12, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Biotricity stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Additional Tools for Biotricity Stock Analysis

When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.